Clinical trial
Comparison of Intravenous Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Proliferative Lupus Nephritis
NCT02645565 is registered in ClinicalTrials.gov with Jawaharlal Institute of Postgraduate Medical Education & Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Intravenous Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Proliferative Lupus Nephritis
- Lead sponsor
- Jawaharlal Institute of Postgraduate Medical Education & Research
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- December 31, 2016
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.